DIPG-86. INVESTIGATING THE TUMOR ENVIRONMENT AND SIGNALING DEPENDENCIES DRIVING DIFFUSE MIDLINE GLIOMA TUMOR INITIATION …
BACKGROUND Diffuse Midline Glioma (DMG) is a incurable tumor affecting children.
Recent genomic investigations have identified a recurrent H3K27M mutation which induces …
Recent genomic investigations have identified a recurrent H3K27M mutation which induces …
DIPG-06. FUNCTIONAL MULTI-OMIC PROFILING OF THE LANDSCAPE OF DIFFUSE MIDLINE GLIOMAS TO IDENTIFY THERAPEUTIC VULNERABILITIES
IJ Findlay, D Staudt, RJ Duchatel, ER Jackson… - Neuro …, 2024 - ncbi.nlm.nih.gov
BACKGROUND Diffuse midline glioma (DMG) is a devastating pediatric high-grade glioma
(pHGG) located along the midline structures of the brain and spine. Palliative radiotherapy is …
(pHGG) located along the midline structures of the brain and spine. Palliative radiotherapy is …
Identification of Targetable Pathway Dependencies in Diffuse Midline Glioma
SG PARACKAL - bridges.monash.edu
Diffuse Midline Glioma (DMG), is a highly aggressive and infiltrative paediatric brain tumour
with currently no known cure. Characterisation of DMG has since revealed a diverse …
with currently no known cure. Characterisation of DMG has since revealed a diverse …
Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies
Diffuse midline glioma (DMG) is a deadly pediatric and adolescent central nervous system
(CNS) tumor localized along the midline structures of the brain atop the spinal cord. With a …
(CNS) tumor localized along the midline structures of the brain atop the spinal cord. With a …
DIPG-06. Uncovering the FACTs in Diffuse Midline Glioma (DMG)
H Holliday, A Ehteda, A Khan, B Krug… - Neuro …, 2022 - ncbi.nlm.nih.gov
Effective treatments are urgently needed for the incurable paediatric brainstem tumour
Diffuse Midline Glioma (DMG). Most DMGs contain Histone H3 mutations (H3K27M), which …
Diffuse Midline Glioma (DMG). Most DMGs contain Histone H3 mutations (H3K27M), which …
Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma
MM Georgescu, MZ Islam, Y Li, ML Circu… - Acta Neuropathologica …, 2020 - Springer
Diffuse midline gliomas (DMGs) are aggressive pediatric brain tumors with dismal prognosis
due to therapy-resistant tumor growth and invasion. We performed the first integrated …
due to therapy-resistant tumor growth and invasion. We performed the first integrated …
DIPG-11. DISSECTING THE DIFFUSE MIDLINE GLIOMA TUMOR MICROENVIRONMENT COMMUNICATIONS USING MULTI-OMICS APPROACHES
R Collot, CR Moreno, A Wezenaar, A Zomer… - Neuro …, 2023 - ncbi.nlm.nih.gov
Diffuse midline glioma (DMG) represents a highly aggressive pediatric brain tumor with no
chance of survival. Treatment options are urgently needed, and efforts have been put …
chance of survival. Treatment options are urgently needed, and efforts have been put …
Transcriptomic and Proteomic Spatial Profiling of Pediatric and Adult Diffuse Midline Glioma H3 K27-Altered, Reveals Region Specific Differences and Limited …
Diffuse midline glioma, H3 K27-altered (DMG-Alt) are highly aggressive malignancies of the
central nervous system (CNS) that primarily affect the pediatric population. Large scale …
central nervous system (CNS) that primarily affect the pediatric population. Large scale …
DIPG-57. A systems biology approach to defining and targeting master regulator dependencies from bulk and single-Cell RNA-seq in diffuse midline glioma (DMG)
EC Fernández, J Wang, A Griffin, H Minns… - Neuro …, 2022 - academic.oup.com
Diffuse midline glioma (DMG) are fatal pediatric brain tumors with no effective systemic
therapies. Molecular profiling demonstrates epigenetic dysregulation and heterogeneity …
therapies. Molecular profiling demonstrates epigenetic dysregulation and heterogeneity …
DIPG-55. DISSECTING THE ECOSYSTEM OF PEDIATRIC DIFFUSE MIDLINE GLIOMA
J Morscio, S Jacobs, F De Smet - Neuro-Oncology, 2024 - ncbi.nlm.nih.gov
BACKGROUND Pediatric gliomas are heterogeneous tumors encompassing high grade
(pHGG) and low grade (pLGG) subtypes. For tumors not amenable to surgery, in particular …
(pHGG) and low grade (pLGG) subtypes. For tumors not amenable to surgery, in particular …
相关搜索
- therapy resistance midline glioma
- pathway dependencies midline glioma
- dipg 06 midline gliomas
- global activation midline glioma
- spatial profiling midline glioma
- mrna and protein midline glioma
- rna seq midline glioma
- global activation therapy resistance
- oncogenic pathways therapy resistance
- dipg 06 therapeutic vulnerabilities
- dipg 57 midline glioma
- dipg 55 midline glioma
- therapeutic vulnerabilities midline gliomas
- oncogenic pathways midline glioma